PROFUSA, INC.

IPO

Pioneering real-time biochemistry that drives AI-led, personalized healthcare technologies.

Public · South San Francisco, United States · Founded 2015 · $57.0M raised

Employees
11–50
Founded
2015
Business Model
B2B
Total Funding
$57.0M
Last Round
$12.0M Convertible NoteOct 2025
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Profusa is a commercial-stage digital health company (NASDAQ: PFSA) pioneering tissue-integrating biosensors that continuously monitor body chemistry in real time. Their Lumee™ platform measures tissue oxygen and glucose levels and has received FDA and CE authorization. Originally SBIR-funded through DARPA and NIH, Profusa now operates as a publicly traded company focused on AI-led personalized healthcare.

Summary

PROFUSA, INC. is a Biotech company based in South San Francisco, United States, founded in 2015. It has raised $57.0M in total across 2 rounds, most recently a $12.0M Convertible Note round in Oct 2025. Investors include VMS Investment Group, Tasly Pharmaceutical Group and Maxim Integrated.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

ConvertibleConvertible NoteOct 2025
$12.0M

Sign up to see all 3 events

Funding: Series C through Convertible Note. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

PROFUSA, INC. on Indexed.vc
<a href="https://indexed.vc/companies/profusa-inc"><img src="https://indexed.vc/api/badge/company/profusa-inc" alt="PROFUSA, INC. on Indexed.vc" width="260" height="76" /></a>